Login

Sustainability Spotlight: Joao Bento on CTT Portugal Post | João Bento - CEO of CTT Correios de Portugal, S.A. 00:10:00

Share On Facebook Share On Twitter

João Bento is the CEO of CTT Correios de Portugal, S.A.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Lithium Australia: Pioneering Vertically Integrated Lithium Processing Technology
00:10:00
Built by and for cybersecurity startups and investors|Kevin Mandia,Founding Partner,Ballistic Ventures
00:10:00
Claudio Erba, CEO, and Alessio Artuffo, CRO of Docebo Inc., provide insights in "The View From The C-Suite," juxtaposed with Warren Buffett's endorsement of Greg Abel for Berkshire Hathaway.|Claudio is the founder and CEO of Docebo
00:10:00
Company will focus on the continued development and commercialization of T cell therapies|Peter L. Hoang,CEO,TapImmune Inc
00:10:00
"Meet the Manager: Shane Hurst on Navigating Global Trends in Infrastructure Investment" | Shane Hurst - Managing Director and Portfolio Manager of the Legg Mason
00:10:00
Bill Gates and Larry Fink on the Future of Clean Energy | Larry Fink, CEO , BlackRock Inc.
00:10:00
Exploring Financial Planning Administration: Roles, Qualifications, and Career Pathways
00:10:00
Sykes Pumps Embraces Stage V: Commitment to Environmental Impact Reduction | Jean-Jacques Murray – Chairman of Andrews Sykes Group
00:10:00
Kyle Detwiler brings extensive investment and leadership experience to Clever Leaves | Kyle Detwiler, CEO, Clever Leaves Holdings Inc.
00:10:00
Ben Lightburn Discusses Filament Health's Mission to Standardize Natural Psychedelics | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Wes Edens on Brightline West and the Rise of Passenger Rail Industry |Wes Edens, Co-Founder, Fortress Investment.
00:10:00
companies in the enterprise consumer and healthcare spaces|Jeremy Levine,Partner,Bessemer Venture Partners

© 2017 - Neuhu+